Free Trial

20 Stocks Wall Street Analysts Love the Most

Every trading day, between 500 and 800 new recommendations and research reports are issued by sell-side equities research analysts. There are between 300 and 500 brokerages and research houses that issue ratings, price targets and recommendations and more than 5,000 securities around the world that regularly receive coverage from research analysts.

MarketBeat has tracked more than 170,000 distinct analyst recommendations in the last 12 months alone. Given the volume of ratings changes that occur each day, it can be difficult to sift through the noise.

Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when more than a dozen different analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same stock.

This slide show lists the 20 companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

#1 - Rio Tinto Group (NYSE:RIO)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
8 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$73.00 (16.6% Upside)

About Rio Tinto Group

Rio Tinto Group logoRio Tinto Group engages in exploring, mining, and processing mineral resources worldwide. The company operates through Iron Ore, Aluminium, Copper, and Minerals Segments. The Iron Ore segment engages in the iron ore mining, and salt and gypsum production in Western Australia. The Aluminum segment is involved in bauxite mining; alumina refining; and aluminium smelting. More about Rio Tinto Group
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/16/2025BarclaysReiterated RatingOverweight ➝ Overweight
4/9/2025Morgan StanleyDowngradeOverweight ➝ Equal Weight
3/27/2025DZ BankUpgradeHold ➝ Strong-Buy
3/18/2025JPMorgan Chase & Co.Initiated CoverageOverweight
2/28/2025Clarkson CapitalUpgradeStrong-Buy
1/6/2025Jefferies Financial GroupLower Price TargetBuy ➝ Buy$83.00 ➝ $73.00
10/16/2024MacquarieReiterated RatingOutperform ➝ Neutral
10/2/2024Berenberg BankUpgradeHold ➝ Buy
7/31/2024Royal Bank of CanadaUpgradeHold
7/23/2024Hsbc Global ResUpgradeStrong-Buy

#2 - SS&C Technologies (NASDAQ:SSNC)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
6 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$91.86 (15.4% Upside)

About SS&C Technologies

SS&C Technologies logoSS&C Technologies Holdings, Inc engages in the development and provision of software solutions to the financial services and healthcare industries. It operates through the following geographical segments: United States, Europe, Middle East and Africa, Asia Pacific and Japan, Canada, and the Americas, excluding the United States and Canada. More about SS&C Technologies
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/28/2025DA DavidsonLower Price TargetBuy ➝ Buy$100.00 ➝ $94.00
4/25/2025Raymond JamesLower Price TargetStrong-Buy ➝ Strong-Buy$95.00 ➝ $90.00
4/25/2025JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$90.00 ➝ $86.00
4/25/2025Needham & Company LLCLower Price TargetBuy ➝ Buy$105.00 ➝ $90.00
4/11/2025DA DavidsonLower Price TargetBuy ➝ Buy$102.00 ➝ $100.00
2/10/2025DA DavidsonBoost Price TargetBuy ➝ Buy$92.00 ➝ $102.00
2/7/2025Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$86.00 ➝ $96.00
2/7/2025Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$85.00 ➝ $95.00
2/7/2025Needham & Company LLCBoost Price TargetBuy ➝ Buy$90.00 ➝ $105.00
2/3/2025UBS GroupBoost Price TargetBuy ➝ Buy$92.00 ➝ $93.00

#3 - Jones Lang LaSalle (NYSE:JLL)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$315.83 (33.8% Upside)

About Jones Lang LaSalle

Jones Lang LaSalle logoJones Lang LaSalle Incorporated operates as a commercial real estate and investment management company. It engages in the buying, building, occupying, managing, and investing in a commercial, industrial, hotel, residential, and retail properties in Americas, Europe, the Middle East, Africa, and the Asia Pacific. More about Jones Lang LaSalle
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/17/2025Keefe, Bruyette & WoodsLower Price TargetOutperform ➝ Outperform$325.00 ➝ $280.00
4/11/2025UBS GroupLower Price TargetBuy ➝ Buy$340.00 ➝ $305.00
4/10/2025JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$327.00 ➝ $285.00
1/24/2025Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$317.00 ➝ $320.00
12/16/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$263.00 ➝ $327.00
12/10/2024Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$292.00 ➝ $325.00
12/6/2024The Goldman Sachs GroupInitiated CoverageBuy$352.00
11/25/2024Wolfe ResearchUpgradePeer Perform ➝ Outperform$353.00
11/12/2024Keefe, Bruyette & WoodsBoost Price TargetMarket Perform ➝ Market Perform$280.00 ➝ $292.00
8/8/2024Keefe, Bruyette & WoodsBoost Price TargetMarket Perform ➝ Market Perform$240.00 ➝ $250.00

#4 - Royalty Pharma (NASDAQ:RPRX)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
4 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$42.50 (24.9% Upside)

About Royalty Pharma

Royalty Pharma logoRoyalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. More about Royalty Pharma
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/16/2025Morgan StanleyInitiated CoverageOverweight$51.00
3/28/2025CitigroupReiterated RatingBuy ➝ Buy
12/24/2024TD CowenUpgradeStrong-Buy
10/25/2024CitigroupLower Price TargetBuy ➝ Buy$60.00 ➝ $40.00
8/14/2024The Goldman Sachs GroupBoost Price TargetBuy ➝ Buy$50.00 ➝ $51.00
7/11/2024Morgan StanleyBoost Price TargetOverweight ➝ Overweight$48.00 ➝ $51.00
6/3/2024UBS GroupDowngradeBuy ➝ Neutral$28.00
4/12/2024Bank of AmericaLower Price TargetBuy ➝ Buy$40.00 ➝ $38.00
2/20/2024JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$45.00 ➝ $42.00
2/20/2024The Goldman Sachs GroupLower Price TargetBuy ➝ Buy$56.00 ➝ $50.00

#5 - Dycom Industries (NYSE:DY)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$200.22 (2.9% Upside)

About Dycom Industries

Dycom Industries logoDycom Industries, Inc provides specialty contracting services to the telecommunications infrastructure and utility industries in the United States. The company offers engineering services to telecommunications providers, including the planning and design of aerial, underground, and buried fiber optic, copper, and coaxial cable systems; wireless networks in connection with the deployment of macro cell and new small cell sites; and program and project management and inspection personnel. More about Dycom Industries
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/21/2025JPMorgan Chase & Co.Initiated CoverageOverweight$200.00
4/16/2025KeyCorpLower Price TargetOverweight ➝ Overweight$201.00 ➝ $183.00
4/3/2025Wells Fargo & CompanyLower Price TargetOverweight ➝ Overweight$215.00 ➝ $200.00
3/19/2025B. RileyLower Price TargetBuy ➝ Buy$234.00 ➝ $200.00
3/18/2025B. RileyUpgradeStrong-Buy
2/27/2025KeyCorpLower Price TargetOverweight ➝ Overweight$229.00 ➝ $201.00
2/4/2025Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$210.00 ➝ $215.00
1/8/2025KeyCorpBoost Price TargetOverweight ➝ Overweight$227.00 ➝ $229.00
11/19/2024DA DavidsonReiterated RatingBuy ➝ Buy$210.00 ➝ $210.00
11/15/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$200.00 ➝ $215.00

#6 - Coca-Cola FEMSA (NYSE:KOF)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$106.50 (14.9% Upside)

About Coca-Cola FEMSA

Coca-Cola FEMSA logoCoca-Cola FEMSA, SAB. de C.V., a franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Brazil, Argentina, and Uruguay. The company offers sparkling beverages, including colas and flavored sparkling beverages; waters; other non-carbonated beverages comprising juice drinks, coffee, teas, milk, value-added dairy products, sports and energy drinks, and plant-based drinks; and alcoholic beverages, such as hard seltzer under the Topo Chico brand name. More about Coca-Cola FEMSA
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/5/2025UBS GroupBoost Price TargetBuy ➝ Buy$106.00 ➝ $109.00
4/11/2025JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$107.00 ➝ $110.00
3/4/2025BarclaysBoost Price TargetOverweight ➝ Overweight$99.00 ➝ $105.00
10/30/2024BarclaysLower Price TargetOverweight ➝ Overweight$110.00 ➝ $108.00
10/29/2024CitigroupUpgradeNeutral ➝ Buy$93.00 ➝ $102.00
9/3/2024The Goldman Sachs GroupUpgradeNeutral ➝ Buy
7/31/2024BarclaysBoost Price TargetOverweight ➝ Overweight$105.00 ➝ $110.00
7/15/2024BarclaysLower Price TargetOverweight ➝ Overweight$115.00 ➝ $105.00
7/10/2024UBS GroupLower Price TargetBuy ➝ Buy$112.00 ➝ $102.00
4/16/2024UBS GroupBoost Price TargetBuy ➝ Buy$109.00 ➝ $112.00

#7 - Dolby Laboratories (NYSE:DLB)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$102.33 (32.0% Upside)

About Dolby Laboratories

Dolby Laboratories logoDolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices. More about Dolby Laboratories
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/15/2025Tigress FinancialInitiated CoverageBuy ➝ Buy$116.00 ➝ $112.00
5/2/2025Barrington ResearchReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00
5/2/2025Rosenblatt SecuritiesLower Price TargetBuy ➝ Buy$100.00 ➝ $95.00
2/13/2025Barrington ResearchReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00
1/30/2025Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$100.00 ➝ $100.00
1/27/2025Barrington ResearchReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00
1/23/2025Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$100.00 ➝ $100.00
11/20/2024Barrington ResearchReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00
11/20/2024Rosenblatt SecuritiesBoost Price TargetBuy ➝ Buy$98.00 ➝ $100.00
9/20/2024Barrington ResearchReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00

#8 - Tencent Music Entertainment Group (NYSE:TME)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
8 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$15.00 (9.9% Downside)

About Tencent Music Entertainment Group

Tencent Music Entertainment Group logoTencent Music Entertainment Group operates online music entertainment platforms to provide music streaming, online karaoke, and live streaming services in the People's Republic of China. It offers QQ Music, Kugou Music, and Kuwo Music that enable users to discover music in personalized ways; long-form audio content, including audiobooks, podcasts and talk shows, as well as music-oriented video content comprising music videos, live performances, and short videos; and WeSing, which enables users to sing along from its library of karaoke songs and share their performances in audio or video formats with friends. More about Tencent Music Entertainment Group
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/14/2025Sanford C. BernsteinReiterated RatingOutperform ➝ Outperform
5/13/2025Morgan StanleyReiterated RatingOverweight ➝ Overweight
4/8/2025Nomura SecuritiesUpgradeStrong-Buy
3/26/2025Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
3/19/2025MizuhoBoost Price TargetOutperform ➝ Outperform$16.00 ➝ $17.00
3/18/2025Morgan StanleyReiterated RatingOverweight ➝ Overweight
1/21/2025Morgan StanleyUpgradeEqual Weight ➝ Overweight$13.00 ➝ $13.00
11/6/2024BarclaysInitiated CoverageOverweight$16.00
11/4/2024Sanford C. BernsteinInitiated CoverageOutperform$14.00
9/25/2024Morgan StanleyDowngradeOverweight ➝ Equal Weight$15.00 ➝ $13.00

#9 - Telefônica Brasil (NYSE:VIV)

Consensus Rating
Moderate Buy
Rating Score
2.6
Ratings Breakdown
3 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$17.23 (75.6% Upside)

About Telefônica Brasil

Telefônica Brasil logoTelefônica Brasil SA, together with its subsidiaries, operates as a mobile telecommunications company in Brazil. Its fixed line services portfolio includes local, domestic long-distance, and international long-distance calls; and mobile portfolio comprises voice and broadband internet access through 3G, 4G, 4.5G, and 5G, as well as mobile value-added and wireless roaming services. More about Telefônica Brasil
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/30/2025The Goldman Sachs GroupBoost Price TargetBuy ➝ Buy$9.20 ➝ $10.30
3/3/2025BarclaysUpgradeEqual Weight ➝ Overweight$23.60 ➝ $23.00
2/27/2025ScotiabankLower Price TargetSector Perform ➝ Sector Perform$20.80 ➝ $18.40
12/19/2024The Goldman Sachs GroupLower Price TargetBuy ➝ Buy$21.20 ➝ $18.40
12/9/2024New Street ResearchDowngradeBuy ➝ Neutral
11/25/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $23.60
9/20/2024ScotiabankBoost Price TargetSector Perform ➝ Sector Perform$18.40 ➝ $20.80
8/1/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$22.00 ➝ $23.00
7/11/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight
5/9/2024BarclaysLower Price TargetEqual Weight ➝ Equal Weight$26.00 ➝ $24.00

#10 - US Foods (NYSE:USFD)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
11 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$73.00 (4.7% Downside)

About US Foods

US Foods logoUS Foods Holding Corp., together with its subsidiaries, engages in marketing, sale, and distribution of fresh, frozen, and dry food and non-food products to foodservice customers in the United States. The company's customers include independently owned single and multi-unit restaurants, regional concepts, national restaurant chains, hospitals, nursing homes, hotels and motels, country clubs, government and military organizations, colleges and universities, and retail locations. More about US Foods
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/12/2025GuggenheimReiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
5/9/2025UBS GroupBoost Price TargetBuy ➝ Buy$83.00 ➝ $84.00
5/9/2025Morgan StanleyBoost Price TargetOverweight ➝ Overweight$81.00 ➝ $84.00
4/14/2025GuggenheimReiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
2/18/2025Piper SandlerBoost Price TargetOverweight ➝ Overweight$75.00 ➝ $77.00
2/14/2025UBS GroupBoost Price TargetBuy ➝ Buy$77.00 ➝ $83.00
2/14/2025Truist FinancialBoost Price TargetBuy ➝ Buy$78.00 ➝ $80.00
2/14/2025BarclaysBoost Price TargetOverweight ➝ Overweight$82.00 ➝ $85.00
1/21/2025Morgan StanleyBoost Price TargetOverweight ➝ Overweight$76.00 ➝ $82.00
1/16/2025Truist FinancialBoost Price TargetBuy ➝ Buy$74.00 ➝ $78.00

#11 - Nebius Group (NASDAQ:NBIS)

Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$41.33 (10.8% Upside)

About Nebius Group

Nebius Group logoNebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability. More about Nebius Group
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/6/2025Northland CapmkUpgradeStrong-Buy
5/6/2025Northland SecuritiesInitiated CoverageOutperform$34.00
4/14/2025DA DavidsonLower Price TargetBuy ➝ Buy$50.00 ➝ $30.00
3/4/2025BWS FinancialReiterated RatingBuy ➝ Buy$60.00 ➝ $60.00
2/25/2025DA DavidsonInitiated CoverageBuy$50.00
2/21/2025BWS FinancialBoost Price TargetBuy ➝ Buy$51.00 ➝ $60.00
1/28/2025BWS FinancialReiterated RatingBuy ➝ Buy$51.00 ➝ $51.00
1/13/2025BWS FinancialInitiated CoverageBuy$51.00

#12 - Valero Energy (NYSE:VLO)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
15 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$151.93 (11.9% Upside)

About Valero Energy

Valero Energy logoValero Energy Corporation manufactures, markets, and sells petroleum-based and low-carbon liquid transportation fuels and petrochemical products in the United States, Canada, the United Kingdom, Ireland, Latin America, Mexico, Peru, and internationally. It operates through three segments: Refining, Renewable Diesel, and Ethanol. More about Valero Energy
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/13/2025MizuhoBoost Price TargetOutperform ➝ Outperform$158.00 ➝ $166.00
5/13/2025The Goldman Sachs GroupUpgradeNeutral ➝ Buy$127.00 ➝ $154.00
5/12/2025BarclaysBoost Price TargetOverweight ➝ Overweight$140.00 ➝ $141.00
5/9/2025Piper SandlerLower Price TargetOverweight ➝ Overweight$144.00 ➝ $140.00
4/28/2025UBS GroupLower Price TargetBuy ➝ Buy$160.00 ➝ $150.00
4/28/2025JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$152.00 ➝ $147.00
4/28/2025The Goldman Sachs GroupUpgradeSell ➝ Neutral$115.00 ➝ $127.00
4/25/2025TD CowenLower Price TargetBuy$121.00 ➝ $118.00
4/24/2025Morgan StanleyLower Price TargetOverweight ➝ Overweight$160.00 ➝ $145.00
4/11/2025ScotiabankLower Price TargetSector Outperform ➝ Sector Outperform$156.00 ➝ $136.00

#13 - Karman (NYSE:KRMN)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$43.50 (2.2% Downside)

About Karman

Karman logoWe specialize in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Our integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense (“DoD”) and space sector initiatives. More about Karman
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/14/2025Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$38.00 ➝ $44.00
5/14/2025Robert W. BairdBoost Price TargetOutperform ➝ Outperform$40.00 ➝ $50.00
4/3/2025Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$35.00 ➝ $38.00
3/10/2025Baird R WUpgradeStrong-Buy
3/10/2025Royal Bank of CanadaInitiated CoverageOutperform$35.00
3/10/2025Robert W. BairdInitiated CoverageOutperform$40.00
3/10/2025CitigroupInitiated CoverageBuy$42.00
3/10/2025William BlairInitiated CoverageOutperform
3/10/2025Evercore ISIInitiated CoverageOutperform$38.00

#14 - Mplx (NYSE:MPLX)

Consensus Rating
Moderate Buy
Rating Score
2.6
Ratings Breakdown
6 Buy Ratings, 1 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$55.50 (6.5% Upside)

About Mplx

Mplx logoMPLX LP engages in the operation of midstream energy infrastructure and logistics assets, and distribution fuels services. It operates through the Crude Oil and Products Logistics and Natural Gas and NGL Services segments. The Crude Oil and Products Logistics segment transports, stores, distributes, and markets crude oil, asphalt, refined petroleum products, and water. More about Mplx
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/12/2025BarclaysLower Price TargetOverweight ➝ Overweight$55.00 ➝ $52.00
3/17/2025Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$55.00 ➝ $58.00
3/14/2025BarclaysBoost Price TargetOverweight ➝ Overweight$52.00 ➝ $55.00
3/11/2025Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $62.00
2/6/2025Raymond JamesBoost Price TargetOutperform ➝ Outperform$55.00 ➝ $60.00
2/6/2025Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$54.00 ➝ $59.00
1/13/2025BarclaysBoost Price TargetOverweight ➝ Overweight$49.00 ➝ $52.00
12/18/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$53.00 ➝ $54.00
11/19/2024Truist FinancialBoost Price TargetBuy ➝ Buy$48.00 ➝ $55.00
11/18/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$50.00 ➝ $52.00

#15 - Agnico Eagle Mines (NYSE:AEM)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
10 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$124.40 (16.9% Upside)

About Agnico Eagle Mines

Agnico Eagle Mines logoAgnico Eagle Mines Limited, a gold mining company, exploration, development, and production of precious metals. It explores for gold. The company's mines are located in Canada, Australia, Finland and Mexico, with exploration and development activities in Canada, Australia, Europe, Latin America, and the United States. More about Agnico Eagle Mines
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/25/2025Cfra ResearchUpgradeStrong-Buy
4/16/2025BMO Capital MarketsInitiated CoverageOutperform$181.00
4/15/2025BMO Capital MarketsUpgradeStrong-Buy
4/14/2025ScotiabankReiterated RatingOutperform ➝ Outperform
4/14/2025ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$105.00 ➝ $126.00
4/11/2025UBS GroupBoost Price TargetNeutral ➝ Neutral$110.00 ➝ $115.00
4/8/2025Bank of AmericaBoost Price TargetBuy ➝ Buy$119.00 ➝ $142.00
4/4/2025Raymond JamesBoost Price TargetOutperform ➝ Outperform$105.00 ➝ $130.00
4/4/2025Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$110.00 ➝ $115.00
3/31/2025CitigroupBoost Price TargetBuy$100.00 ➝ $140.00

#16 - MACOM Technology Solutions (NASDAQ:MTSI)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
9 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$130.50 (5.7% Upside)

About MACOM Technology Solutions

MACOM Technology Solutions logoMACOM Technology Solutions Holdings, Inc, together with its subsidiaries, designs and manufactures analog semiconductor solutions for use in wireless and wireline applications across the radio frequency (RF), microwave, millimeter wave, and lightwave spectrum in the United States, China, Australia, Japan, Malaysia, Singapore, South Korea, Taiwan, Thailand, and internationally. More about MACOM Technology Solutions
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/9/2025BarclaysBoost Price TargetOverweight ➝ Overweight$125.00 ➝ $150.00
5/9/2025BenchmarkReiterated RatingBuy ➝ Buy$160.00 ➝ $160.00
4/22/2025BarclaysLower Price TargetOverweight ➝ Overweight$160.00 ➝ $125.00
4/17/2025Stifel NicolausLower Price TargetBuy ➝ Buy$150.00 ➝ $120.00
4/16/2025Bank of AmericaLower Price TargetBuy ➝ Buy$160.00 ➝ $130.00
4/11/2025Truist FinancialInitiated CoverageBuy$125.00
4/9/2025BNP ParibasUpgradeNeutral ➝ Outperform$135.00
2/10/2025Northland CapmkUpgradeHold ➝ Strong-Buy
2/10/2025BenchmarkReiterated RatingBuy ➝ Buy$160.00 ➝ $160.00
2/10/2025Northland SecuritiesUpgradeMarket Perform ➝ Outperform$105.00 ➝ $140.00

#17 - Adtalem Global Education (NYSE:ATGE)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$135.67 (0.8% Upside)

About Adtalem Global Education

Adtalem Global Education logoAdtalem Global Education Inc provides workforce solutions worldwide. It operates through three segments, Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment operates Chamberlain University. More about Adtalem Global Education
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/12/2025BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$115.00 ➝ $132.00
5/9/2025Barrington ResearchBoost Price TargetOutperform ➝ Outperform$120.00 ➝ $140.00
4/23/2025Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$135.00
4/15/2025Barrington ResearchReiterated RatingOutperform ➝ Outperform$120.00 ➝ $120.00
2/3/2025BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$108.00 ➝ $115.00
1/31/2025Barrington ResearchBoost Price TargetOutperform ➝ Outperform$115.00 ➝ $120.00
1/17/2025Barrington ResearchBoost Price TargetOutperform ➝ Outperform$95.00 ➝ $115.00
10/30/2024BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$84.00 ➝ $90.00
10/30/2024Barrington ResearchBoost Price TargetOutperform ➝ Outperform$90.00 ➝ $95.00
8/29/2024Barrington ResearchReiterated RatingOutperform ➝ Outperform$90.00 ➝ $90.00

#18 - BioMarin Pharmaceutical (NASDAQ:BMRN)

Consensus Rating
Moderate Buy
Rating Score
2.7
Ratings Breakdown
17 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$93.45 (57.7% Upside)

About BioMarin Pharmaceutical

BioMarin Pharmaceutical logoBioMarin Pharmaceutical Inc develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. More about BioMarin Pharmaceutical
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/5/2025The Goldman Sachs GroupLower Price TargetBuy ➝ Buy$124.00 ➝ $104.00
5/2/2025CitigroupLower Price TargetNeutral ➝ Neutral$82.00 ➝ $78.00
2/24/2025OppenheimerUpgradeMarket Perform ➝ Outperform$98.00
2/20/2025WedbushReiterated RatingOutperform$94.00
2/20/2025CitigroupBoost Price TargetNeutral ➝ Neutral$81.00 ➝ $82.00
2/20/2025ScotiabankBoost Price TargetSector Perform ➝ Sector Perform$78.00 ➝ $80.00
2/20/2025Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$70.00 ➝ $70.00
2/20/2025Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
2/20/2025UBS GroupBoost Price TargetBuy ➝ Buy$109.00 ➝ $113.00
2/20/2025Piper SandlerBoost Price TargetOverweight ➝ Overweight$122.00 ➝ $126.00

#19 - Equinix (NASDAQ:EQIX)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
25 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$1,004.89 (14.7% Upside)

About Equinix

Equinix logoEquinix (Nasdaq: EQIX) is the world's digital infrastructure company . Digital leaders harness Equinix's trusted platform to bring together and interconnect foundational infrastructure at software speed. Equinix enables organizations to access all the right places, partners and possibilities to scale with agility, speed the launch of digital services, deliver world-class experiences and multiply their value, while supporting their sustainability goals.
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/12/2025Truist FinancialLower Price TargetBuy ➝ Buy$990.00 ➝ $986.00
5/5/2025CitigroupBoost Price TargetBuy ➝ Buy$970.00 ➝ $990.00
5/1/2025CowenReiterated RatingBuy ➝ Buy
5/1/2025BNP ParibasUpgradeStrong-Buy
5/1/2025JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$1,200.00 ➝ $1,200.00
5/1/2025Stifel NicolausBoost Price TargetBuy ➝ Buy$1,030.00 ➝ $1,050.00
5/1/2025TD SecuritiesBoost Price TargetBuy ➝ Buy$978.00 ➝ $1,018.00
4/28/2025New Street ResearchUpgradeStrong-Buy
4/22/2025ScotiabankLower Price TargetSector Outperform ➝ Sector Outperform$1,040.00 ➝ $1,030.00
4/17/2025CitigroupLower Price TargetBuy ➝ Buy$1,020.00 ➝ $970.00

#20 - Evergy (NASDAQ:EVRG)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$72.44 (8.2% Upside)

About Evergy

Evergy logoEvergy, Inc, together with its subsidiaries, engages in the generation, transmission, distribution, and sale of electricity in the United States. The company generates electricity through coal, landfill gas, uranium, and natural gas and oil sources, as well as solar, wind, other renewable sources. It serves residences, commercial firms, industrials, municipalities, and other electric utilities. More about Evergy
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/16/2025CitigroupBoost Price TargetBuy ➝ Buy$77.00 ➝ $79.00
5/13/2025BMO Capital MarketsInitiated CoverageOutperform$75.00
5/8/2025LADENBURG THALM/SH SHUpgradeStrong-Buy
4/28/2025UBS GroupUpgradeNeutral ➝ Buy$68.00 ➝ $78.00
4/22/2025BarclaysBoost Price TargetOverweight ➝ Overweight$72.00 ➝ $73.00
3/21/2025UBS GroupBoost Price TargetNeutral ➝ Neutral$66.00 ➝ $68.00
3/17/2025LADENBURG THALM/SH SHUpgradeStrong-Buy
3/7/2025BarclaysBoost Price TargetOverweight ➝ Overweight$62.00 ➝ $72.00
1/27/2025BarclaysLower Price TargetOverweight ➝ Overweight$65.00 ➝ $62.00
1/23/2025GuggenheimUpgradeNeutral ➝ Buy

More Investing Slideshows: